0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Diagnostic Imaging Agent Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-36P14922
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Diagnostic Imaging Agent Market Research Report 2023
BUY CHAPTERS

Global Diagnostic Imaging Agent Market Research Report 2025

Code: QYRE-Auto-36P14922
Report
May 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Diagnostic Imaging Agent Market

The global market for Diagnostic Imaging Agent was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Diagnostic Imaging Agent is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Diagnostic Imaging Agent is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Diagnostic Imaging Agent include GE HealthCare, Bracco Diagnostic, Guerbet, Mallinckrodt, Lantheus, Yantai Dongcheng, Foshan Rui Diao Pharmaceutical, Cardinal Health, Blue Earth Diagnostics, Bayer AG, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Diagnostic Imaging Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Imaging Agent.
The Diagnostic Imaging Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Diagnostic Imaging Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Imaging Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Diagnostic Imaging Agent Market Report

Report Metric Details
Report Name Diagnostic Imaging Agent Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GE HealthCare, Bracco Diagnostic, Guerbet, Mallinckrodt, Lantheus, Yantai Dongcheng, Foshan Rui Diao Pharmaceutical, Cardinal Health, Blue Earth Diagnostics, Bayer AG, Abx Advanced Biochemical, Eli Lilly and Company, Jubilant Pharma Limited, Navidea
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Diagnostic Imaging Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Diagnostic Imaging Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Diagnostic Imaging Agent Market report?

Ans: The main players in the Diagnostic Imaging Agent Market are GE HealthCare, Bracco Diagnostic, Guerbet, Mallinckrodt, Lantheus, Yantai Dongcheng, Foshan Rui Diao Pharmaceutical, Cardinal Health, Blue Earth Diagnostics, Bayer AG, Abx Advanced Biochemical, Eli Lilly and Company, Jubilant Pharma Limited, Navidea

What are the Application segmentation covered in the Diagnostic Imaging Agent Market report?

Ans: The Applications covered in the Diagnostic Imaging Agent Market report are Tumor, Heart Disease, Gastrointestinal Disease, Neurological Disease

What are the Type segmentation covered in the Diagnostic Imaging Agent Market report?

Ans: The Types covered in the Diagnostic Imaging Agent Market report are Conjugated Imaging Agent, Metabolic Imaging Agent, Blood Flow and Blood Volume Imaging Agents

Recommended Reports

Medical Imaging Technology

Imaging Agent Markets

AI & Digital Diagnostics

1 Diagnostic Imaging Agent Market Overview
1.1 Product Definition
1.2 Diagnostic Imaging Agent by Type
1.2.1 Global Diagnostic Imaging Agent Market Value Comparison by Type (2024 VS 2031)
1.2.2 Conjugated Imaging Agent
1.2.3 Metabolic Imaging Agent
1.2.4 Blood Flow and Blood Volume Imaging Agents
1.3 Diagnostic Imaging Agent by Application
1.3.1 Global Diagnostic Imaging Agent Market Value by Application (2024 VS 2031)
1.3.2 Tumor
1.3.3 Heart Disease
1.3.4 Gastrointestinal Disease
1.3.5 Neurological Disease
1.4 Global Diagnostic Imaging Agent Market Size Estimates and Forecasts
1.4.1 Global Diagnostic Imaging Agent Revenue 2020-2031
1.4.2 Global Diagnostic Imaging Agent Sales 2020-2031
1.4.3 Global Diagnostic Imaging Agent Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Diagnostic Imaging Agent Market Competition by Manufacturers
2.1 Global Diagnostic Imaging Agent Sales Market Share by Manufacturers (2020-2025)
2.2 Global Diagnostic Imaging Agent Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Diagnostic Imaging Agent Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Diagnostic Imaging Agent, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diagnostic Imaging Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diagnostic Imaging Agent, Product Type & Application
2.7 Global Key Manufacturers of Diagnostic Imaging Agent, Date of Enter into This Industry
2.8 Global Diagnostic Imaging Agent Market Competitive Situation and Trends
2.8.1 Global Diagnostic Imaging Agent Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Diagnostic Imaging Agent Players Market Share by Revenue
2.8.3 Global Diagnostic Imaging Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Diagnostic Imaging Agent Market Scenario by Region
3.1 Global Diagnostic Imaging Agent Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Diagnostic Imaging Agent Sales by Region: 2020-2031
3.2.1 Global Diagnostic Imaging Agent Sales by Region: 2020-2025
3.2.2 Global Diagnostic Imaging Agent Sales by Region: 2026-2031
3.3 Global Diagnostic Imaging Agent Revenue by Region: 2020-2031
3.3.1 Global Diagnostic Imaging Agent Revenue by Region: 2020-2025
3.3.2 Global Diagnostic Imaging Agent Revenue by Region: 2026-2031
3.4 North America Diagnostic Imaging Agent Market Facts & Figures by Country
3.4.1 North America Diagnostic Imaging Agent Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Diagnostic Imaging Agent Sales by Country (2020-2031)
3.4.3 North America Diagnostic Imaging Agent Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Diagnostic Imaging Agent Market Facts & Figures by Country
3.5.1 Europe Diagnostic Imaging Agent Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Diagnostic Imaging Agent Sales by Country (2020-2031)
3.5.3 Europe Diagnostic Imaging Agent Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diagnostic Imaging Agent Market Facts & Figures by Region
3.6.1 Asia Pacific Diagnostic Imaging Agent Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Diagnostic Imaging Agent Sales by Region (2020-2031)
3.6.3 Asia Pacific Diagnostic Imaging Agent Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Diagnostic Imaging Agent Market Facts & Figures by Country
3.7.1 Latin America Diagnostic Imaging Agent Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Diagnostic Imaging Agent Sales by Country (2020-2031)
3.7.3 Latin America Diagnostic Imaging Agent Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diagnostic Imaging Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Diagnostic Imaging Agent Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Diagnostic Imaging Agent Sales by Country (2020-2031)
3.8.3 Middle East and Africa Diagnostic Imaging Agent Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diagnostic Imaging Agent Sales by Type (2020-2031)
4.1.1 Global Diagnostic Imaging Agent Sales by Type (2020-2025)
4.1.2 Global Diagnostic Imaging Agent Sales by Type (2026-2031)
4.1.3 Global Diagnostic Imaging Agent Sales Market Share by Type (2020-2031)
4.2 Global Diagnostic Imaging Agent Revenue by Type (2020-2031)
4.2.1 Global Diagnostic Imaging Agent Revenue by Type (2020-2025)
4.2.2 Global Diagnostic Imaging Agent Revenue by Type (2026-2031)
4.2.3 Global Diagnostic Imaging Agent Revenue Market Share by Type (2020-2031)
4.3 Global Diagnostic Imaging Agent Price by Type (2020-2031)
5 Segment by Application
5.1 Global Diagnostic Imaging Agent Sales by Application (2020-2031)
5.1.1 Global Diagnostic Imaging Agent Sales by Application (2020-2025)
5.1.2 Global Diagnostic Imaging Agent Sales by Application (2026-2031)
5.1.3 Global Diagnostic Imaging Agent Sales Market Share by Application (2020-2031)
5.2 Global Diagnostic Imaging Agent Revenue by Application (2020-2031)
5.2.1 Global Diagnostic Imaging Agent Revenue by Application (2020-2025)
5.2.2 Global Diagnostic Imaging Agent Revenue by Application (2026-2031)
5.2.3 Global Diagnostic Imaging Agent Revenue Market Share by Application (2020-2031)
5.3 Global Diagnostic Imaging Agent Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GE HealthCare
6.1.1 GE HealthCare Company Information
6.1.2 GE HealthCare Description and Business Overview
6.1.3 GE HealthCare Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GE HealthCare Diagnostic Imaging Agent Product Portfolio
6.1.5 GE HealthCare Recent Developments/Updates
6.2 Bracco Diagnostic
6.2.1 Bracco Diagnostic Company Information
6.2.2 Bracco Diagnostic Description and Business Overview
6.2.3 Bracco Diagnostic Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bracco Diagnostic Diagnostic Imaging Agent Product Portfolio
6.2.5 Bracco Diagnostic Recent Developments/Updates
6.3 Guerbet
6.3.1 Guerbet Company Information
6.3.2 Guerbet Description and Business Overview
6.3.3 Guerbet Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Guerbet Diagnostic Imaging Agent Product Portfolio
6.3.5 Guerbet Recent Developments/Updates
6.4 Mallinckrodt
6.4.1 Mallinckrodt Company Information
6.4.2 Mallinckrodt Description and Business Overview
6.4.3 Mallinckrodt Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mallinckrodt Diagnostic Imaging Agent Product Portfolio
6.4.5 Mallinckrodt Recent Developments/Updates
6.5 Lantheus
6.5.1 Lantheus Company Information
6.5.2 Lantheus Description and Business Overview
6.5.3 Lantheus Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Lantheus Diagnostic Imaging Agent Product Portfolio
6.5.5 Lantheus Recent Developments/Updates
6.6 Yantai Dongcheng
6.6.1 Yantai Dongcheng Company Information
6.6.2 Yantai Dongcheng Description and Business Overview
6.6.3 Yantai Dongcheng Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Yantai Dongcheng Diagnostic Imaging Agent Product Portfolio
6.6.5 Yantai Dongcheng Recent Developments/Updates
6.7 Foshan Rui Diao Pharmaceutical
6.7.1 Foshan Rui Diao Pharmaceutical Company Information
6.7.2 Foshan Rui Diao Pharmaceutical Description and Business Overview
6.7.3 Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Product Portfolio
6.7.5 Foshan Rui Diao Pharmaceutical Recent Developments/Updates
6.8 Cardinal Health
6.8.1 Cardinal Health Company Information
6.8.2 Cardinal Health Description and Business Overview
6.8.3 Cardinal Health Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Cardinal Health Diagnostic Imaging Agent Product Portfolio
6.8.5 Cardinal Health Recent Developments/Updates
6.9 Blue Earth Diagnostics
6.9.1 Blue Earth Diagnostics Company Information
6.9.2 Blue Earth Diagnostics Description and Business Overview
6.9.3 Blue Earth Diagnostics Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Blue Earth Diagnostics Diagnostic Imaging Agent Product Portfolio
6.9.5 Blue Earth Diagnostics Recent Developments/Updates
6.10 Bayer AG
6.10.1 Bayer AG Company Information
6.10.2 Bayer AG Description and Business Overview
6.10.3 Bayer AG Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bayer AG Diagnostic Imaging Agent Product Portfolio
6.10.5 Bayer AG Recent Developments/Updates
6.11 Abx Advanced Biochemical
6.11.1 Abx Advanced Biochemical Company Information
6.11.2 Abx Advanced Biochemical Description and Business Overview
6.11.3 Abx Advanced Biochemical Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Abx Advanced Biochemical Diagnostic Imaging Agent Product Portfolio
6.11.5 Abx Advanced Biochemical Recent Developments/Updates
6.12 Eli Lilly and Company
6.12.1 Eli Lilly and Company Company Information
6.12.2 Eli Lilly and Company Description and Business Overview
6.12.3 Eli Lilly and Company Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Eli Lilly and Company Diagnostic Imaging Agent Product Portfolio
6.12.5 Eli Lilly and Company Recent Developments/Updates
6.13 Jubilant Pharma Limited
6.13.1 Jubilant Pharma Limited Company Information
6.13.2 Jubilant Pharma Limited Description and Business Overview
6.13.3 Jubilant Pharma Limited Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Jubilant Pharma Limited Diagnostic Imaging Agent Product Portfolio
6.13.5 Jubilant Pharma Limited Recent Developments/Updates
6.14 Navidea
6.14.1 Navidea Company Information
6.14.2 Navidea Description and Business Overview
6.14.3 Navidea Diagnostic Imaging Agent Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Navidea Diagnostic Imaging Agent Product Portfolio
6.14.5 Navidea Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diagnostic Imaging Agent Industry Chain Analysis
7.2 Diagnostic Imaging Agent Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diagnostic Imaging Agent Production Mode & Process Analysis
7.4 Diagnostic Imaging Agent Sales and Marketing
7.4.1 Diagnostic Imaging Agent Sales Channels
7.4.2 Diagnostic Imaging Agent Distributors
7.5 Diagnostic Imaging Agent Customer Analysis
8 Diagnostic Imaging Agent Market Dynamics
8.1 Diagnostic Imaging Agent Industry Trends
8.2 Diagnostic Imaging Agent Market Drivers
8.3 Diagnostic Imaging Agent Market Challenges
8.4 Diagnostic Imaging Agent Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Diagnostic Imaging Agent Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Diagnostic Imaging Agent Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Diagnostic Imaging Agent Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Diagnostic Imaging Agent Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Diagnostic Imaging Agent Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Diagnostic Imaging Agent Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Diagnostic Imaging Agent Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Diagnostic Imaging Agent Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Diagnostic Imaging Agent, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Diagnostic Imaging Agent, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Diagnostic Imaging Agent, Product Type & Application
 Table 12. Global Key Manufacturers of Diagnostic Imaging Agent, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Diagnostic Imaging Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Imaging Agent as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Diagnostic Imaging Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Diagnostic Imaging Agent Sales by Region (2020-2025) & (K Units)
 Table 18. Global Diagnostic Imaging Agent Sales Market Share by Region (2020-2025)
 Table 19. Global Diagnostic Imaging Agent Sales by Region (2026-2031) & (K Units)
 Table 20. Global Diagnostic Imaging Agent Sales Market Share by Region (2026-2031)
 Table 21. Global Diagnostic Imaging Agent Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Diagnostic Imaging Agent Revenue Market Share by Region (2020-2025)
 Table 23. Global Diagnostic Imaging Agent Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Diagnostic Imaging Agent Revenue Market Share by Region (2026-2031)
 Table 25. North America Diagnostic Imaging Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Diagnostic Imaging Agent Sales by Country (2020-2025) & (K Units)
 Table 27. North America Diagnostic Imaging Agent Sales by Country (2026-2031) & (K Units)
 Table 28. North America Diagnostic Imaging Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Diagnostic Imaging Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Diagnostic Imaging Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Diagnostic Imaging Agent Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Diagnostic Imaging Agent Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Diagnostic Imaging Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Diagnostic Imaging Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Diagnostic Imaging Agent Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Diagnostic Imaging Agent Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Diagnostic Imaging Agent Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Diagnostic Imaging Agent Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Diagnostic Imaging Agent Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Diagnostic Imaging Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Diagnostic Imaging Agent Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Diagnostic Imaging Agent Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Diagnostic Imaging Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Diagnostic Imaging Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Diagnostic Imaging Agent Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Diagnostic Imaging Agent Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Diagnostic Imaging Agent Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Diagnostic Imaging Agent Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Diagnostic Imaging Agent Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Diagnostic Imaging Agent Sales (K Units) by Type (2020-2025)
 Table 51. Global Diagnostic Imaging Agent Sales (K Units) by Type (2026-2031)
 Table 52. Global Diagnostic Imaging Agent Sales Market Share by Type (2020-2025)
 Table 53. Global Diagnostic Imaging Agent Sales Market Share by Type (2026-2031)
 Table 54. Global Diagnostic Imaging Agent Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Diagnostic Imaging Agent Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Diagnostic Imaging Agent Revenue Market Share by Type (2020-2025)
 Table 57. Global Diagnostic Imaging Agent Revenue Market Share by Type (2026-2031)
 Table 58. Global Diagnostic Imaging Agent Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Diagnostic Imaging Agent Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Diagnostic Imaging Agent Sales (K Units) by Application (2020-2025)
 Table 61. Global Diagnostic Imaging Agent Sales (K Units) by Application (2026-2031)
 Table 62. Global Diagnostic Imaging Agent Sales Market Share by Application (2020-2025)
 Table 63. Global Diagnostic Imaging Agent Sales Market Share by Application (2026-2031)
 Table 64. Global Diagnostic Imaging Agent Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Diagnostic Imaging Agent Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Diagnostic Imaging Agent Revenue Market Share by Application (2020-2025)
 Table 67. Global Diagnostic Imaging Agent Revenue Market Share by Application (2026-2031)
 Table 68. Global Diagnostic Imaging Agent Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Diagnostic Imaging Agent Price (US$/Unit) by Application (2026-2031)
 Table 70. GE HealthCare Company Information
 Table 71. GE HealthCare Description and Business Overview
 Table 72. GE HealthCare Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. GE HealthCare Diagnostic Imaging Agent Product
 Table 74. GE HealthCare Recent Developments/Updates
 Table 75. Bracco Diagnostic Company Information
 Table 76. Bracco Diagnostic Description and Business Overview
 Table 77. Bracco Diagnostic Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Bracco Diagnostic Diagnostic Imaging Agent Product
 Table 79. Bracco Diagnostic Recent Developments/Updates
 Table 80. Guerbet Company Information
 Table 81. Guerbet Description and Business Overview
 Table 82. Guerbet Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Guerbet Diagnostic Imaging Agent Product
 Table 84. Guerbet Recent Developments/Updates
 Table 85. Mallinckrodt Company Information
 Table 86. Mallinckrodt Description and Business Overview
 Table 87. Mallinckrodt Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Mallinckrodt Diagnostic Imaging Agent Product
 Table 89. Mallinckrodt Recent Developments/Updates
 Table 90. Lantheus Company Information
 Table 91. Lantheus Description and Business Overview
 Table 92. Lantheus Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Lantheus Diagnostic Imaging Agent Product
 Table 94. Lantheus Recent Developments/Updates
 Table 95. Yantai Dongcheng Company Information
 Table 96. Yantai Dongcheng Description and Business Overview
 Table 97. Yantai Dongcheng Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Yantai Dongcheng Diagnostic Imaging Agent Product
 Table 99. Yantai Dongcheng Recent Developments/Updates
 Table 100. Foshan Rui Diao Pharmaceutical Company Information
 Table 101. Foshan Rui Diao Pharmaceutical Description and Business Overview
 Table 102. Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Foshan Rui Diao Pharmaceutical Diagnostic Imaging Agent Product
 Table 104. Foshan Rui Diao Pharmaceutical Recent Developments/Updates
 Table 105. Cardinal Health Company Information
 Table 106. Cardinal Health Description and Business Overview
 Table 107. Cardinal Health Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Cardinal Health Diagnostic Imaging Agent Product
 Table 109. Cardinal Health Recent Developments/Updates
 Table 110. Blue Earth Diagnostics Company Information
 Table 111. Blue Earth Diagnostics Description and Business Overview
 Table 112. Blue Earth Diagnostics Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Blue Earth Diagnostics Diagnostic Imaging Agent Product
 Table 114. Blue Earth Diagnostics Recent Developments/Updates
 Table 115. Bayer AG Company Information
 Table 116. Bayer AG Description and Business Overview
 Table 117. Bayer AG Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Bayer AG Diagnostic Imaging Agent Product
 Table 119. Bayer AG Recent Developments/Updates
 Table 120. Abx Advanced Biochemical Company Information
 Table 121. Abx Advanced Biochemical Description and Business Overview
 Table 122. Abx Advanced Biochemical Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Abx Advanced Biochemical Diagnostic Imaging Agent Product
 Table 124. Abx Advanced Biochemical Recent Developments/Updates
 Table 125. Eli Lilly and Company Company Information
 Table 126. Eli Lilly and Company Description and Business Overview
 Table 127. Eli Lilly and Company Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Eli Lilly and Company Diagnostic Imaging Agent Product
 Table 129. Eli Lilly and Company Recent Developments/Updates
 Table 130. Jubilant Pharma Limited Company Information
 Table 131. Jubilant Pharma Limited Description and Business Overview
 Table 132. Jubilant Pharma Limited Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Jubilant Pharma Limited Diagnostic Imaging Agent Product
 Table 134. Jubilant Pharma Limited Recent Developments/Updates
 Table 135. Navidea Company Information
 Table 136. Navidea Description and Business Overview
 Table 137. Navidea Diagnostic Imaging Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Navidea Diagnostic Imaging Agent Product
 Table 139. Navidea Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Diagnostic Imaging Agent Distributors List
 Table 143. Diagnostic Imaging Agent Customers List
 Table 144. Diagnostic Imaging Agent Market Trends
 Table 145. Diagnostic Imaging Agent Market Drivers
 Table 146. Diagnostic Imaging Agent Market Challenges
 Table 147. Diagnostic Imaging Agent Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Diagnostic Imaging Agent
 Figure 2. Global Diagnostic Imaging Agent Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Diagnostic Imaging Agent Market Share by Type: 2024 & 2031
 Figure 4. Conjugated Imaging Agent Product Picture
 Figure 5. Metabolic Imaging Agent Product Picture
 Figure 6. Blood Flow and Blood Volume Imaging Agents Product Picture
 Figure 7. Global Diagnostic Imaging Agent Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Diagnostic Imaging Agent Market Share by Application: 2024 & 2031
 Figure 9. Tumor
 Figure 10. Heart Disease
 Figure 11. Gastrointestinal Disease
 Figure 12. Neurological Disease
 Figure 13. Global Diagnostic Imaging Agent Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Diagnostic Imaging Agent Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Diagnostic Imaging Agent Sales (2020-2031) & (K Units)
 Figure 16. Global Diagnostic Imaging Agent Average Price (US$/Unit) & (2020-2031)
 Figure 17. Diagnostic Imaging Agent Report Years Considered
 Figure 18. Diagnostic Imaging Agent Sales Share by Manufacturers in 2024
 Figure 19. Global Diagnostic Imaging Agent Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Diagnostic Imaging Agent Players: Market Share by Revenue in Diagnostic Imaging Agent in 2024
 Figure 21. Diagnostic Imaging Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Diagnostic Imaging Agent Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Diagnostic Imaging Agent Sales Market Share by Country (2020-2031)
 Figure 24. North America Diagnostic Imaging Agent Revenue Market Share by Country (2020-2031)
 Figure 25. United States Diagnostic Imaging Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Diagnostic Imaging Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Diagnostic Imaging Agent Sales Market Share by Country (2020-2031)
 Figure 28. Europe Diagnostic Imaging Agent Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Diagnostic Imaging Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Diagnostic Imaging Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Diagnostic Imaging Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Diagnostic Imaging Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Diagnostic Imaging Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Diagnostic Imaging Agent Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Diagnostic Imaging Agent Revenue Market Share by Region (2020-2031)
 Figure 36. China Diagnostic Imaging Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Diagnostic Imaging Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Diagnostic Imaging Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Diagnostic Imaging Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Diagnostic Imaging Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Diagnostic Imaging Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Diagnostic Imaging Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Diagnostic Imaging Agent Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Diagnostic Imaging Agent Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Diagnostic Imaging Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Diagnostic Imaging Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Diagnostic Imaging Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Diagnostic Imaging Agent Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Diagnostic Imaging Agent Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Diagnostic Imaging Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Diagnostic Imaging Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Diagnostic Imaging Agent Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Diagnostic Imaging Agent by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Diagnostic Imaging Agent by Type (2020-2031)
 Figure 55. Global Diagnostic Imaging Agent Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Diagnostic Imaging Agent by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Diagnostic Imaging Agent by Application (2020-2031)
 Figure 58. Global Diagnostic Imaging Agent Price (US$/Unit) by Application (2020-2031)
 Figure 59. Diagnostic Imaging Agent Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS